Hi Sanjeev,

No hard feelings here either... Reasonable people can debate
differences of opinions without getting upset. I was quite encouraged
when I thought your methodology was the obvious answer to the HIPAA
testing problem. Unfortunately, as I delved further into the IGs I
found it to not be nearly as clear cut as it had seemed at first.

My point still stands. If the HIPAA IGs (and the HIPAA conflict
resolution process) are so clear to everyone, why is it that running
the same exact data through 3 or 4 different validation products, based
on the exact same IGs and resolution process, gets you 3 or 4 different
results this late in the game? How do you design test cases for a
so-called standard that is so open to such widely differing
interpretation? 

I do not have the exact email you (or someone from your company) had
sent out explaining what the status of the test cases you were
generously offering to the WEDI-SNIP community were, but I do remember
you stating that you got a lot of variation in results depending on
where you ran your test cases. 

This is not a sane way to set a standard for such a huge undertaking,
to expect (realistically) that everyone will be operating on the same
set of assumptions when it is implemented. I would love to be hired on
as an expert witness when the government tries to fine someone for not
being HIPAA compliant. That will be the real growth industry of the
next few years!




__________________________________________________
Do You Yahoo!?
HotJobs - Search Thousands of New Jobs
http://www.hotjobs.com

Please note that it may take up to 72 hours to process your request.
<P>The WEDI SNIP listserv to which you are subscribed is not moderated.  The
discussions on this listserv therefore represent the views of the individual
participants, and do not necessarily represent the views of the WEDI Board of
Directors nor WEDI SNIP.  If you wish to receive an official opinion, post
your question to the WEDI SNIP Issues Database at
http://snip.wedi.org/tracking/.
Posting of advertisements or other commercial use of this listserv is
specifically prohibited.

Reply via email to